C-QWENCE
The advancement in __________ and in Human phage _______ libraries, in particular, have _______ discovery of many new ___________ and treatments for a ____ range of diseases.
However so far ___ Human phage libraries have ________ on donors from North _______ and Europe where populations ____ only limited exposure to ________. What we are working ____ is a purely India _____ Antibody Library.
With more diverse _______ pool than any other ______ and with exposures to __________ diseases and changes in ___________ never seen in Americas & Europe, Premas Antibody Library, ________ a wealth of novel ________ and protective immune responses.
That’s demonstrated in ___ unique profiles of individual __________ isolated from the libraries. ___ VH CDR3 regions have _ wide range in lengths, ____ show unique characteristics in ____ critical in binding region. ___ when compared with antibody _________, >99% of the sequences ____ shown to be unique ______ them easy to patent.
Together the characteristics ______ in high affinity and _____ specificity antibodies. By tapping ____ this great wealth, we ___ find new and better ____ to create medicines for _______, metabolic diseases, infectious diseases, ______ disorders and more.
